Skip to content
All Podcasts – Lifestyle
Author:
Panome Bio
TD2 Oncology and Panome Bio Partner to Advance Translational Oncology Through Integrated Multi-Omics Capabilities
May 27, 2026
Panome Bio and Audubon Bioscience Partner to Deliver End-to-End FFPE Biospecimen and Metabolomics Solutions for Cancer Researchers
April 16, 2026
Panome Bio Launches Exposomics Services to Measure the Chemical Drivers of Human Disease
March 6, 2026
Panome Bio Introduces MassID™, a Major Advance in Untargeted Metabolomics Data Analysis for Biomarker Discovery and Drug Development
March 4, 2026